Announcements

Opyl Rights Issue Results

Resignation of Director – Dr Julian Chick

Notice of initial substantial holder – 13 Feb 2023

Opyl enters into MSA and new clinical trial recruitment

Update to the announcement regarding the extension of the closing date of the rights issue

Non-Renounceable Rights Issue Extension of Closing Date

Becoming A Substantial Holder

Rights Issue Timetable – Change to Dispatch Date

Rights Issue Offer Booklet

Opyl Opens Rights Issue

Letter to Ineligible Shareholders

Clarification Statement to Opyl Completes Placement and Launches Rights Issue